Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Race Oncology Ltd. ( (AU:RAC) ).
Race Oncology Ltd announced the quotation of 57,105 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of September 11, 2025. This move is part of the company’s strategy to enhance its market presence and potentially increase its capital base, thereby strengthening its position in the oncology sector.
More about Race Oncology Ltd.
Race Oncology Ltd is a company operating in the oncology sector, focusing on the development and commercialization of cancer treatments. The company is engaged in the pharmaceutical industry, aiming to provide innovative therapeutic solutions to address unmet medical needs in cancer care.
Average Trading Volume: 126,058
Technical Sentiment Signal: Buy
Current Market Cap: A$298.8M
See more data about RAC stock on TipRanks’ Stock Analysis page.